Inhibition of Cxcr2 Plays a Pivotal Role in Re-Sensitizing Ovarian Cancer to Cisplatin Treatment
AuthID
P-00V-2T3
P-00V-2T3
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service